This invention is directed to a method of treating a patient with diseased or damaged organs comprising administering to said patient a bioremodelable collagen-containing material which promotes the production of structural collagen, vascularization and epithelialization by the ingrowth of patient cells, wherein the material undergoes controlled biodegradation occurring with adequate living cell replacement such that the original implanted graft is bioremodeled by the patient's living cells.

 
Web www.patentalert.com

< Implant

< Ceramic manufactures

> Method of determining a genetic relationship to at least one individual in a group of famous individuals using a combination of genetic markers

> Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification

~ 00235